Procter & Gamble Hygiene & Health Care Ltd.
₹6,855.45-₹69.75 (-1.0%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹40,121 Cr
- P/E
- 48.5x
- Revenue
- ₹3,374 Cr
Price chart
Technical chartScreen technicals →-48.9% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- +0.8%
- 3M
- -19.1%
- 6M
- -32.4%
- 1Y
- -48.9%
- 5Y
- -52.4%
52-week range
Day change -₹69.75 (-1.0%) from ₹6,925 to ₹6,855 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in PGHH, bought on each weekday since 2021.
AI Summary
Indian StockStrengths1
- Large-cap with ₹40.1K Cr market capitalisation
Concerns0
Rule-based from financial data. Not advice.
About the company
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments.
Read moreShow less
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also provides baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home, personal and skin care, and oral products. The company sells its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brands through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.
- Sector
- Healthcare
- Shares outstanding
- 3.2 Cr shares
- ISIN
- INE179A01014
- BSE code
- 500459
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹40,121 Cr
- P/E
- 48.5x
- P/B
- 43.1x
- Earnings yield
- 2.1%
- 52-week high
- ₹13,795.00
- 52-week low
- ₹6,673.20
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹3,374 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -19.8%
Revenue and net profit
Annual revenue, with net profit as the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2021 | ₹3,574 Cr | ₹652 Cr |
| FY2022 | ₹3,901 Cr | ₹576 Cr |
| FY2023 | ₹3,918 Cr | ₹678 Cr |
| FY2024 | ₹4,206 Cr | ₹675 Cr |
Cash flows
FY2025: ₹593 Cr from operations, ₹559 Cr free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2021 | ₹863 Cr | ₹870 Cr |
| FY2022 | ₹573 Cr | ₹546 Cr |
| FY2023 | ₹826 Cr | ₹816 Cr |
| FY2024 | ₹470 Cr | ₹471 Cr |
| FY2025 | ₹593 Cr | ₹559 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
- Cash from operations
- ₹593 Cr
- Free cash flow
- ₹559 Cr+18.7%1Y
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | — | — | — | — | ₹593 Cr | ₹559 Cr | — | — | — |
Monthly returns
Month-by-month returns of PGHH across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Liabilities and equity | ₹1,755 Cr |
| Equity capital | ₹32 Cr |
| Reserves | ₹705 Cr |
| Borrowings | ₹2 Cr |
| Other liabilities | ₹1,015 Cr |
| Assets | ₹1,755 Cr |
| Fixed assets | ₹131 Cr |
| Capital work in progress | ₹41 Cr |
| Investments | ₹0 Cr |
| Other assets | ₹1,583 Cr |
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
PGHH trades at 48.5x earnings against a peer median of 52.6x.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Procter & Gamble Hygiene & Health Care Ltd.PGHHthis company | ₹40,121 Cr | 48.5x | 43.1x | — | — |
| GlaxoSmithkline Pharmaceuticals Ltd.GLAXO | ₹40,108 Cr | 42.4x | 23.5x | — | — |
| Narayana Hrudayalaya LimitedNH | ₹38,566 Cr | 83.0x | 16.6x | 23.1% | 54.0x |
| Ipca Laboratories Ltd.IPCALAB | ₹38,240 Cr | 39.5x | 5.2x | 8.3% | 32.5x |
| Anthem Biosciences LimitedANTHEM | ₹35,376 Cr | 66.2x | 12.4x | 19.4% | 61.4x |
| Ajanta Pharma Ltd.AJANTPHARM | ₹34,058 Cr | 35.8x | 8.3x | 23.6% | 27.3x |
| Global Health LimitedMEDANTA | ₹31,404 Cr | 59.8x | 8.3x | 16.0% | 37.3x |
| Aster DM Healthcare LimitedASTERDM | ₹31,356 Cr | 92.8x | 7.1x | 5.4% | 78.2x |
| Emcure Pharmaceuticals LimitedEMCURE | ₹29,399 Cr | 67.9x | 9.1x | 8.3% | 53.5x |
| Peer median | — | 52.6x | 5.9x | 12.1% | 38.3x |
Year-to-date ROI
PGHH since 1 January, against earlier years.
Historical volatility
PGHH's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
| Line | FYundefined |
|---|---|
| RevenueSales | — |
| Costs | |
| Interest | — |
| Expenses | — |
| Operating profitOperating Profit | — |
| Other income and charges | |
| Profit before tax | — |
| Tax | |
| Net profitNet Profit | — |
| Per share |
| Line | FY2025 |
|---|---|
| Liabilities and equityTotal Liabilities | ₹1,755 Cr |
| Equity capitalEquity Capital | ₹32 Cr |
| Reserves | ₹705 Cr |
| Borrowings | ₹2 Cr |
| Other liabilitiesOther Liabilities | ₹1,015 Cr |
| AssetsTotal Assets | ₹1,755 Cr |
| Fixed assetsFixed Assets | ₹131 Cr |
| Capital work in progressCWIP | ₹41 Cr |
| Investments | ₹0 Cr |
| Other assetsOther Assets | ₹1,583 Cr |
| Line | FY2025 |
|---|---|
| Operating cash flowCash from Operating Activity | ₹593 Cr |
| Investing cash flowCash from Investing Activity | -₹34 Cr |
| Financing cash flowCash from Financing Activity | -₹666 Cr |
| Change in cashNet Cash Flow | -₹107 Cr |
Learn while you research
Academy chapters picked for Procter & Gamble Hygiene & Health Care Ltd. and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Valuation Multiples ExplainedThis stock trades at a P/E of 48.5, learn when high multiples are justified.6 min read
- 04 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
- 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read